Drug repurposing of fostamatinib against cancer via potential cytotoxicity and immune checkpoint regulation
{{output}}
Acute myeloid leukemia (AML), originating from myeloid hematopoietic stem/progenitor cells, is a malignant hematological disorder. Resistance to current treatments, especially in FLT3-ITD AML cases, urgently demands the development of novel therapeutics. In th... ...
